Literature DB >> 24101212

The apoptosis of peripheral blood lymphocytes promoted by hyperbaric oxygen treatment contributes to attenuate the severity of early stage acute pancreatitis in rats.

Xuewei Bai1, Zengfu Song, Yanmei Zhou, Shangha Pan, Feng Wang, Zuoming Guo, Maitao Jiang, Gang Wang, Rui Kong, Bei Sun.   

Abstract

The aim of this study was to investigate the immunoregulatory effects of hyperbaric oxygen (HBO) via promoting the apoptosis of peripheral blood lymphocytes (PBLs) to attenuate the severity of early stage acute pancreatitis (AP) in rats. Additionally, the persistence of the HBO treatment effects was evaluated. One hundred and twenty male Wistar rats were randomized into four groups: sham, AP, AP + normobaric oxygen (NBO), and AP + HBO. Each group consisted of 30 rats. Four hours after the induction of AP, the 30 rats in the AP + NBO group were given normobaric oxygen treatment with 100 % oxygen at 1 atm for 90 min. The 30 rats in the AP + HBO group received 100 % oxygen at 2.5 atm for 90 min, with a compression/decompression time of 15 min. The 30 rats in the AP group remained untreated. At 6, 12, and 24 h after the induction of AP, surviving rats from each group were sacrificed, and the blood and tissue samples were collected for the following measurements: the partial pressure of oxygen (PaO2) and oxygen saturation (SaO2) of the arterial blood, the levels of serum amylase, lipase, interleukin-2 (IL-2), interferon-γ (IFN-γ), interleukin-10 (IL-10), hepatocyte growth factor (HGF), and reactive oxygen species (ROS), and the mitochondrial membrane potential (∆Ψm) of the PBLs. The expression levels of procaspase-3, caspase-3, procaspase-9, and caspase-9 were also evaluated in the PBLs. Additionally, the apoptosis of PBLs was assessed, and the pancreatic tissues were subjected to a histopathological analysis by pathological grading and scoring. The histopathology of the lung, liver, kidney, duodenum, and heart was also analyzed at 12 h after the induction of AP. Significant differences were found at 6 and 12 h after AP induction. The HBO treatment significantly elevated the PaO2 and SaO2 levels, and the ROS levels in the PBLs. Additionally, HBO downregulated the levels of amylase and lipase. The HBO treatment also reduced the ∆Ψm levels, upregulated the expression of caspase-3 and caspase-9, and increased the apoptosis rate of the PBLs. Moreover, the HBO treatment decreased the serum concentrations of IL-2, IFN-γ and HGF, and reduced the pathological scores of the pancreatic tissue. The histopathological changes of the lung, liver, kidney, duodenum, and heart were also improved. A significant elevation of IL-10 occurred only at the 12-h time point. However, no obvious differences were found at the 24-h time point. This study demonstrated that the HBO treatment can promote the apoptosis of PBLs via a mitochondrial-dependent pathway and inhibit the inflammatory response. These immunoregulatory effects may play an important therapeutic role in attenuating the severity of early stage AP. The repeated administration of HBO or the use of HBO in combination with other approaches may further improve outcomes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24101212     DOI: 10.1007/s10495-013-0911-x

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  13 in total

Review 1.  Hyperbaric oxygen influences chronic wound healing - a cellular level review.

Authors:  J Růžička; J Dejmek; L Bolek; J Beneš; J Kuncová
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

2.  Blockade of C3a/C3aR axis alleviates severe acute pancreatitis-induced intestinal barrier injury.

Authors:  Jiawei Ye; Hui Dai; Yuqi Liu; Bin Yu; Jiyuan Yang; Aihua Fei
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  A new combination therapy in severe acute pancreatitis--hyperbaric oxygen plus 3-aminobenzamide: an experimental study.

Authors:  Volkan Inal; Mehmet Refik Mas; Ahmet Turan Isik; Bilgin Comert; Sezai Aydn; Nukhet Mas; Mehmet Salih Deveci; Ilker Tasci; Levent Yamanel; Esref Cinar; Mehmet Tahir Unal
Journal:  Pancreas       Date:  2015-03       Impact factor: 3.327

4.  Hydrogen sulphide exacerbates acute pancreatitis by over-activating autophagy via AMPK/mTOR pathway.

Authors:  Liang Ji; Le Li; Fengzhi Qu; Guangquan Zhang; Yongwei Wang; Xuewei Bai; Shangha Pan; Dongbo Xue; Gang Wang; Bei Sun
Journal:  J Cell Mol Med       Date:  2016-07-15       Impact factor: 5.310

5.  An investigation of the mechanism of dexmedetomidine in improving postoperative cognitive dysfunction from the perspectives of alleviating neuronal mitochondrial membrane oxidative stress and electrophysiological dysfunction.

Authors:  Jie Chen; Na Shen; Xiaohui Duan; Yaning Guo
Journal:  Exp Ther Med       Date:  2017-12-04       Impact factor: 2.447

6.  The diffuse reduction in spleen density: an indicator of severe acute pancreatitis?

Authors:  Guangdong Shao; Yanmei Zhou; Zengfu Song; Maitao Jiang; Xiaoqian Wang; Xiangren Jin; Bei Sun; Xuewei Bai
Journal:  Biosci Rep       Date:  2017-02-23       Impact factor: 3.840

Review 7.  Application of hyperbaric oxygen in liver transplantation.

Authors:  Hu Lv; Cui-Hong Han; Xue-Jun Sun; Wen-Wu Liu
Journal:  Med Gas Res       Date:  2016-12-30

8.  Effects of Ovariohysterectomy and Hyperbaric Oxygen Therapy on Systemic Inflammation and Oxidation in Dogs.

Authors:  Anais Gautier; Emily C Graff; Lenore Bacek; Eric J Fish; Amelia White; Lee Palmer; Kendon Kuo
Journal:  Front Vet Sci       Date:  2020-01-15

9.  Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft-tissue infection.

Authors:  Morten Hedetoft; Peter Garred; Martin Bruun Madsen; Ole Hyldegaard
Journal:  Physiol Rep       Date:  2021-03

10.  Inhibition of RIPK1-dependent regulated acinar cell necrosis provides protection against acute pancreatitis via the RIPK1/NF-κB/AQP8 pathway.

Authors:  Peng-Yu Duan; Yuan Ma; Xi-Na Li; Feng-Zhi Qu; Liang Ji; Xiao-Yu Guo; Wang-Jun Zhang; Fan Xiao; Le Li; Ji-Sheng Hu; Bei Sun; Gang Wang
Journal:  Exp Mol Med       Date:  2019-08-02       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.